For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers

 
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise.

WIRED Science

Get in-depth coverage of current and future trends in technology, and how they are shaping business,… 

Social links